These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
601 related articles for article (PubMed ID: 3146541)
1. The pituitary-thyroid axis in acromegaly. Eskildsen PC; Kruse A; Kirkegaard C Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541 [TBL] [Abstract][Full Text] [Related]
2. The pituitary-thyroid axis in patients with pituitary disorders. Eskildsen PC; Kruse A; Kirkegaard C Horm Metab Res; 1989 Jul; 21(7):387-90. PubMed ID: 2506120 [TBL] [Abstract][Full Text] [Related]
3. Oral thyrotropin-releasing hormone (TRH) test in acromegaly. Marek J; Límanová Z; Srámková J Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816 [TBL] [Abstract][Full Text] [Related]
4. Central hypothyroidism--various types of TSH responses to TRH stimulation. Trejbal D; Sulla I; Trejbalová L; Lazúrová I; Schwartz P; Machánová Y Endocr Regul; 1994 Mar; 28(1):35-40. PubMed ID: 7949012 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients. Nedvídková J; Felt V Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434 [TBL] [Abstract][Full Text] [Related]
6. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response. Snyder PJ; Utiger RD J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417 [TBL] [Abstract][Full Text] [Related]
7. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone. Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583 [TBL] [Abstract][Full Text] [Related]
8. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism. Sack J; Shafrir Y; Urbach D; Amado O Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951 [TBL] [Abstract][Full Text] [Related]
9. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors. Seo H; Refetoff S; Fang VS Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484 [TBL] [Abstract][Full Text] [Related]
10. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. Lewis GF; Alessi CA; Imperial JG; Refetoff S J Clin Endocrinol Metab; 1991 Oct; 73(4):843-9. PubMed ID: 1653784 [TBL] [Abstract][Full Text] [Related]
11. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573 [TBL] [Abstract][Full Text] [Related]
12. Effect of ACTH-stimulated glucocorticoid hypersecretion on the serum concentrations of thyroxine-binding globulin, thyroxine, triiodothyronine, reverse triiodothyronine and on the TSH-response to TRH. Bános C; Takó J; Salamon F; Györgyi S; Czikkely R Acta Med Acad Sci Hung; 1979; 36(4):381-94. PubMed ID: 233400 [TBL] [Abstract][Full Text] [Related]
13. Dynamics of serum thyrotropin and thyroid hormone changes in fasting. Spencer CA; Lum SM; Wilber JF; Kaptein EM; Nicoloff JT J Clin Endocrinol Metab; 1983 May; 56(5):883-8. PubMed ID: 6403568 [TBL] [Abstract][Full Text] [Related]
14. The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients. Shigemasa C; Abe K; Taniguchi S; Mitani Y; Ueta Y; Adachi T; Urabe K; Tanaka T; Yoshida A; Hori T J Endocrinol Invest; 1988 Apr; 11(4):231-7. PubMed ID: 3137252 [TBL] [Abstract][Full Text] [Related]
15. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients. De Marinis L; Mancini A; Zuppi P; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Valle D Exp Clin Endocrinol Diabetes; 1996; 104(1):67-71. PubMed ID: 8750573 [TBL] [Abstract][Full Text] [Related]
17. Changes in basal and stimulated TSH and other parameters of thyroid function in acromegaly after transsphenoidal surgery. Geelhoed-Duijvestijn PH; Bussemaker JK; Roelfsema F Acta Endocrinol (Copenh); 1989 Aug; 121(2):207-15. PubMed ID: 2505466 [TBL] [Abstract][Full Text] [Related]
18. Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella. Cannavò S; Curtò L; Venturino M; Squadrito S; Almoto B; Narbone MC; Rao R; Trimarchi F J Endocrinol Invest; 2002 Mar; 25(3):236-9. PubMed ID: 11936465 [TBL] [Abstract][Full Text] [Related]
19. Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone. Ballard PL; Ballard RA; Creasy RK; Padbury J; Polk DH; Bracken M; Moya FR; Gross I Pediatr Res; 1992 Dec; 32(6):673-8. PubMed ID: 1287557 [TBL] [Abstract][Full Text] [Related]
20. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly. Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]